Erythromycin lactobionate injection?

Erythromycin Lactobionate Injection
A macrolide antibiotic used for systemic bacterial infections.

---

1. What It Is

• Drug class: Macrolide antibiotic
• Active ingredient: Erythromycin lactobionate (a salt form of erythromycin).
• Form: Parenteral (intravenous or intramuscular) solution.
• Typical concentration: 1 mg/mL (but formulations may vary; check your product label).

2. How It Works

• Binds to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis.
• Effective against many Gram‑positive cocci, some Gram‑negative rods, and atypical organisms (e.g., Mycoplasma, Chlamydia, Legionella).

3. Indications (common uses)

Infection	Typical setting
Severe pneumonia	ICU or hospital setting
Severe skin and soft‑tissue infections	Hospital
Endocarditis (as part of combination therapy)	Hospital
Septicemia	Hospital
Some anaerobic infections (when other options are limited)	Hospital

Note: Always follow local guidelines and susceptibility data; erythromycin is not first‑line for many infections.

4. Dosage & Administration (adult, general)

Route	Dose	Frequency	Comments
IV or IM	1–2 mg/kg IV every 6–12 h	2–3 mg/kg IV q6–12 h	Usually 0.5–1 mg/kg IV q6–8 h (adjust for renal/hepatic function).
IV (loading dose)	1 mg/kg	Single	Often followed by maintenance dosing.

Children: Doses are weight‑based (≈ 5–10 mg/kg/day divided q6–8 h).
Always adjust for renal or hepatic impairment and consult a pediatric pharmacist or physician.

5. How to Give It

• IV: Dilute in 5–20 mL normal saline or 5% dextrose; infuse over at least 30 min.
• IM: Use a 1–1.5 cm needle; inject into a large muscle (gluteus medius or vastus lateralis).
• Avoid injecting into a vein or perineural space.

6. Common Side Effects

• Nausea, vomiting, abdominal pain (especially with IV).
• Hypersensitivity reactions (rash, urticaria, anaphylaxis).
• Rarely, QT prolongation, arrhythmia, or hepatotoxicity.
• Injection site reactions (pain, swelling) for IM.

7. Serious Risks & Precautions

Issue	What to Watch For
QT prolongation	Use cautiously with other QT‑prolonging drugs (e.g., azithromycin, ondansetron).
Liver disease	Avoid in severe hepatic impairment; monitor LFTs.
Kidney disease	Adjust dose; monitor serum creatinine.
Drug interactions	Cimetidine, cimetidine, ranitidine can increase erythromycin levels.
Pregnancy/Breastfeeding	Category B; generally safe, but discuss with provider.
Children under 3 mo	Not recommended; risk of infant botulism from oral erythromycin; injection not indicated.

8. Contraindications

• Known hypersensitivity to erythromycin or macrolides.
• Severe liver dysfunction (unless monitored closely).
• Severe renal impairment without dose adjustment.

9. Drug Interactions (highlighted)

• QT‑prolonging agents (e.g., ondansetron, amiodarone, fluoroquinolones).
• Cimetidine, ranitidine (increase serum levels).
• Statins (rarely, increased myopathy risk).
• Warfarin (rare interactions; monitor INR).
• Other macrolides (additive side‑effect profile).

10. Storage

• Store at 2–8 °C (refrigerated).
• Protect from light; keep in original vial.
• Expire date on label—do not use beyond expiration.

11. How to Handle Waste

• Dispose of unused vial, syringe, and sharps in a sharps container.
• Follow local regulations for pharmaceutical waste.

---

Quick Reference

Feature	Details
Drug	Erythromycin lactobionate
Class	Macrolide antibiotic
Route	IV/IM
Typical Dose	1–2 mg/kg IV q6–12 h (adjusted)
Key Warnings	QT prolongation, hypersensitivity, liver/kidney impairment
Interactions	Cimetidine, QT‑prolongers, other macrolides
Contraindicated	Known macrolide allergy, severe liver disease

---

Final Thought

Erythromycin lactobionate injection is a valuable tool for treating severe bacterial infections, especially when oral therapy is not feasible. Always consult the product monograph, local antibiogram, and a qualified healthcare professional before initiating therapy. If you notice any severe or worsening symptoms, seek medical attention promptly.